We are seeking a strategic and visionary Senior Director, Global Launch Lead to lead the global launch of empasiprubart in Multifocal Motor Neuropathy (MMN), currently in Phase 3. This is a high-impact role that will shape the global launch strategy, drive cross-functional execution, and ensure market readiness for a therapy poised to transform the MMN treatment landscape.You will be a key member of the Global Commercialization community and Chair of the MMN Indication Commercialization Team (ICT), collaborating across geographies and disciplines to deliver an integrated launch plan that maximizes the value of empasiprubart. **Location: Belgium/Switzerland (remote) or in the US, (Prefer East Coast, but not mandatory.)**At argenx, you’ll be part of a purpose-driven organization that values innovation, collaboration, and patient impact. You’ll have the opportunity to lead a global launch that could redefine treatment for MMN and contribute to a legacy of scientific excellence and community-first healthcare.**Key Responsibilities** **Qualifications** 12+ years of commercial experience in pharma/biotech, including marketing and sales Proven success launching rare disease therapies; US launch experience required, international experience strongly preferredStrong cross-functional leadership and stakeholder management skills Excellent project management, communication, and organizational skills Ability to influence without authority and thrive in a fast-paced, dynamic environment **Preferred Skills** Experience launching rare disease biologics globally Strong knowledge of market access strategies, including pricing and reimbursement Strategic thinker with strong analytical skills and data-driven decision-making Familiarity with real-world evidence (RWE), digital engagement, and policy shaping
#J-18808-Ljbffr
#J-18808-Ljbffr